Effect of Nucleos(t)ide Analogs on Patients with Intermediate and Advanced Hepatitis B Virus-Related Hepatocellular Carcinoma.

Zhi-Wei JianXi-Wen WuZhen-Xin ChenJun-Cheng WangJing-Yuan PengXiang-Ming Lao

Published in: Digestive diseases and sciences (2019)

NAs therapy prolongs OS in intermediate- and advanced-stage HBV-related HCC patients initially treated with chemoembolization. After PSM processing, patients who survived ≥ 7 months still benefited from NAs therapy.

Keyphrases

hepatitis b virus
liver failure
newly diagnosed
end stage renal disease
ejection fraction
peritoneal dialysis
mesenchymal stem cells
bone marrow